S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Clinical practice: applying ADC, ICI, PARP data
Panel discussion opens on how to incorporate new data and approvals into treatment decisions for individual patients.
Play episode from 20:36
Transcript
